Japanese
close

FI-MainGroup/Facet-Choice

  • A61K6/00
    		•  Preparations for dentistry HB CC 4C089
  • A61K8/00
    		•  Cosmetics or similar toiletry preparations [2006.01]
    		HB CC 4C083
  • A61K9/00
    		•  Medicinal preparations characterised by special physical form HB CC 4C076
  • A61K31/00
    		•  Medicinal preparations containing organic active ingredients [2]
    		HB CC 4C206
  • A61K33/00
    		•  Medicinal preparations containing inorganic active ingredients [2] HB CC 4C086
  • A61K35/00
    		•  Medicinal preparations containing material or reaction products thereof with undetermined constitution [2]
    		HB CC 4C087
  • A61K36/00
    		•  pharmaceutical preparation having unknown structure and including materials from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    		HB CC 4C088
  • A61K38/00
    		•  Medicinal preparations containing peptides(peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergoline-based peptides A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) [6]
    		HB CC 4C084
  • A61K39/00
    		•  Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53) [2]
    		HB CC 4C085
  • A61K41/00
    		•  Medicinal preparations obtained by treating materials with wave energy or particle radiation HB CC 4C084
  • A61K45/00
    		•  Medicinal preparations containing active ingredients not provided for in groups A61K 31/00-A61K 41/00 [2,6] HB CC 4C084
  • A61K47/00
    		•  Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient [2] HB CC 4C076
  • A61K48/00
    		•  Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy [5] HB CC 4C084
  • A61K49/00
    		•  Preparations for testing in vivo [3] HB CC 4C085
  • A61K50/00
    		•  Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography [ECG] or for transcutaneous drug administration [2006.01] HB CC 4C085
  • A61K51/00
    		•  Preparations containing radioactive substances for use in therapy or testing in vivo
    		HB CC 4C085
    Indexing scheme associated with group A61K 51/00, relating to the nature of the radioactive substance.[6]
  • A61K101:00
    		•  Indexing scheme associated with group A61K 51/00, relating to the nature of the radioactive substance. HB CC
  • A61K103:00
    		•  Radioactive metals [6] HB CC
    Indexing scheme associated with group A61K 36/00, relating to plant parts with medicinal activity.[8]
  • A61K125:00
    		•  Containing or obtained from roots, bulbs, tubers, corms or rhizomes [8] HB CC
  • A61K127:00
    		•  Containing or obtained from leaves [8] HB CC
  • A61K129:00
    		•  Containing or obtained from bark [8] HB CC
  • A61K131:00
    		•  Containing or obtained from seeds, nuts, fruits or grains [8] HB CC
  • A61K133:00
    		•  Containing or obtained from flowers or blossoms [8] HB CC
  • A61K135:00
    		•  Containing or obtained from stems, stalks, branches, twigs or shoots [8] HB CC
    TOP